ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 125 filers reported holding ANI PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.78 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $10,994,000 | -29.7% | 269,876 | +6.5% | 0.07% | -9.0% |
Q4 2019 | $15,631,000 | -15.4% | 253,473 | 0.0% | 0.08% | -23.5% |
Q3 2019 | $18,473,000 | -23.8% | 253,473 | -14.0% | 0.10% | -24.4% |
Q2 2019 | $24,236,000 | +43.1% | 294,852 | +22.8% | 0.14% | +37.8% |
Q1 2019 | $16,941,000 | +60.1% | 240,166 | +2.2% | 0.10% | +48.5% |
Q4 2018 | $10,579,000 | -13.3% | 234,995 | +8.9% | 0.07% | +1.5% |
Q3 2018 | $12,195,000 | +25.3% | 215,695 | +48.0% | 0.06% | +16.1% |
Q2 2018 | $9,732,000 | +14.7% | 145,695 | 0.0% | 0.06% | +16.7% |
Q1 2018 | $8,482,000 | -9.7% | 145,695 | 0.0% | 0.05% | -5.9% |
Q4 2017 | $9,390,000 | -52.1% | 145,695 | -61.0% | 0.05% | -54.5% |
Q3 2017 | $19,610,000 | +11.3% | 373,595 | -0.7% | 0.11% | +8.7% |
Q2 2017 | $17,615,000 | +27.9% | 376,395 | +35.3% | 0.10% | +25.6% |
Q1 2017 | $13,768,000 | +97.7% | 278,095 | +80.2% | 0.08% | +90.7% |
Q4 2015 | $6,964,000 | +30178.3% | 154,336 | +25622.7% | 0.04% | – |
Q3 2015 | $23,000 | – | 600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AIGH Capital Management LLC | 272,801 | $15,838,826 | 7.50% |
Global Alpha Capital Management Ltd. | 525,528 | $30,512,156 | 3.06% |
Rubric Capital Management LP | 847,011 | $49,177,459 | 1.84% |
Ranger Investment Management | 426,848 | $24,782,795 | 1.64% |
Parkman Healthcare Partners LLC | 111,802 | $6,491,224 | 1.19% |
MARATHON CAPITAL MANAGEMENT | 71,670 | $4,161,160 | 1.05% |
Mesirow Financial Investment Management, Inc. | 3,862 | $224,228 | 0.98% |
Deep Track Capital, LP | 400,000 | $23,224,000 | 0.90% |
1492 Capital Management LLC | 18,178 | $1,055,415 | 0.68% |
Phocas Financial Corp. | 75,213 | $4,367,000 | 0.64% |